Advances on cytomegalovirus infection after hematopoietic stem cell transplantation and solid-organ transplantation
10.3760/cma.j.issn.1673-4912.2019.01.006
- VernacularTitle:移植后巨细胞病毒感染的诊疗进展
- Author:
Yinghui CUI
1
;
Feng XU
Author Information
1. 重庆医科大学附属儿童医院重症医学科
- Keywords:
Cytomegalovirus infection;
Hematopoietic stem cell transplantation;
Solid-organ trans-plantation
- From:
Chinese Pediatric Emergency Medicine
2019;26(1):21-26
- CountryChina
- Language:Chinese
-
Abstract:
Cytomegalovirus ( CMV) infection continues to be one of the most common infections after hematopoietic stem cell transplantation and solid-organ transplantation( SOT) ,resulting in significant ad-verse outcomes and mortality. Management of CMV infection after hematopoietic stem cell transplantation and solid-organ transplantation is based on early prevention and early treatment, using of effective antiviral treatment regimens ,thus it has significantly improved the prognosis of CMV infection in transplant recipi-ents. This article reviewed the risk factors,diagnosis,standard treatment and emerging treatment of cytomega-lovirus infection after transplantation,in order to improve the understanding of the disease and understand the novel treatment.
